Ethanol at concentrations obtained in the circulation during moderate-heavy episodic drinking (30-60 mM) causes cerebral artery constriction in several species, including humans. In rodents, ethanol-induced cerebral artery constriction results from ethanol inhibition of large conductance voltage/Ca 2+ i -gated K + (BK) channels in cerebral artery myocytes. Moreover, the smooth muscle-abundant BK β1 accessory subunit is required for ethanol to inhibit cerebral artery myocyte BK channels under physiological Ca 2+ i and voltages and thus constrict cerebral arteries. The molecular bases of these ethanol actions remain unknown. Here, we set to identify the BK β1 region(s) that mediates ethanol-induced inhibition of cerebral artery myocyte BK channels and eventual arterial constriction.
Introduction
Moderate-to-heavy episodic alcohol intake is associated with an increased risk for cerebrovascular disease (Puddey et al., 1999; Yang et al., 2001; Reynolds et al., 2003) . Acute exposure to ethanol at levels reached in circulation during moderate-to-heavy episodic drinking (50 mM) leads to cerebral artery constriction in several species, including humans (Altura and Altura, 1984; Anderson et al., 1993; Zhang et al., 1993; Gordon et al., 1995) . We demonstrated that acute exposure to 50 mM ethanol decreased the activity of large-conductance, voltage-and Ca 2+ -gated K + (BK) channels in rat and mouse cerebral artery myocytes, with this ethanol action leading to cerebral artery constriction (Liu et al., 2004; Bukiya et al., 2009a) . Functional BK channels are tetramers of α subunits (encoded by the Slo1 or KCNMA1 gene in mammals). Each slo1 subunit consists of seven transmembrane domains (S0-S6) and a long cytosolic tail domain (Salkoff et al., 2006) . In most mammalian tissues, slo1 proteins are associated with auxiliary β subunits (Wallner et al., 1999; Brenner et al., 2000; Uebele et al., 2000) . These contain two transmembrane (TM) domains connected by an extracellular loop (EC) and have two short intracellular (IC) ends (Brenner et al., 2000) . The β subunits do not form a functional channel themselves but alter pharmacological Torres et al., 2014) and biophysical properties of BK channels (Brenner et al., 2000; Cox and Aldrich, 2000; Nimigean and Magleby, 2000; Qian and Magleby, 2003; Orio and Latorre, 2005) . Four β types have been identified (encoded by KCNMB1-4), with β1 prevailing in smooth muscle and β4 prevailing in neurons (Brenner et al., 2000) . Remarkably, β1 subunits are required for ethanol to inhibit cerebral artery myocyte BK channels at Ca 2+ i > 2 μM and across a wide voltage range (Bukiya et al., 2009a,b; Kuntamallappanavar and Dopico, 2016) . These conditions include the levels of Ca 2+ i (~4-30 μM) faced by the BK channel that result from depolarization (À40 mV)-induced Ca 2+ -entry and from internal Ca 2+ -release via ryanodine receptor-mediated Ca 2+ sparks. Under these conditions, β1-containing BK channels negatively feedback on depolarization-induced Ca 2+ i entry and on cerebral artery constriction (Pérez et al., 2001) . In contrast, β4-subunits do not support ethanol inhibitory action (Feinberg-Zadek et al., 2008; Martin et al., 2008; Kuntamallappanavar and Dopico, 2016) . All the different β1 regions contribute to the ionic current phenotype of slo1 + β1 channels (Gruslova et al., 2012; Kuntamallappanavar et al., 2014; Castillo et al., 2015) . However, the EC loop is involved in the 17β-oestradiol sensitivity of slo1 + β1 channels expressed in Xenopus oocytes (Valverde et al., 1999) , while β1 TM2 is selectively involved in cholane recognition and eventual vasodilatation (Bukiya et al., 2008) . The specific β1 region(s) that leads to β1-induced facilitation of ethanol inhibition of smooth muscle BK channels, and thus, artery constriction, remains unknown. We addressed this by engineering chimeric β1-β4 proteins, performing protein assays, patch-clamp, reversible cDNA permeabilization and in vitro pressurization of arteries from KCNMB1 K/O mice. Data demonstrate that the β1 TM2 is required for both inhibition of myocyte BK channels and cerebral artery constriction evoked by ethanol.
Methods

Heterologous expression of BK channels
Cbv1 cDNA coding for BK channel-forming α subunits (AY330293) was cloned from rat cerebral artery myocytes as previously described (Liu et al., 2004; Jaggar et al., 2005) . Cbv1 cDNA was cleaved from the bBluescript cloning vector using BamHI (Invitrogen, Carlsbad, CA, USA) and XhoI (Promega, Madison, WI, USA) and directly reinserted into the pOX vector for expression in Xenopus laevis oocytes. Linearization of pOX-cbv1 was done with NotI (Promega) and transcribed in vitro using T3 polymerase. hβ1 and hβ1/β4 chimeric cDNAs were generous gifts from Ligia Toro (University of California, LA). Linearization of pOX vectors containing hβ1 or chimeric hβ1/β4 was carried out with NotI, and the resulting linear cDNAs were transcribed using T3. In all cases, mMessage-mMachine kit (Ambion Life Technologies, Carlsbad, CA, USA) was used for in vitro transcription. hβ1/β4 chimeras were generated in a stepwise fashion by swapping different domains of β1 and β4 so that the swapped region became progressively smaller. Thus, the β1/β4chimeras we used were as follows: (1) a β 1 TMs 4 , which contained hβ4 TMs on a hβ1 'background' (i.e. hβ1 EC loop and IC ends); (2) β 4 TMs 1 , which contained hβ1 TMs on a hβ4 'background' (i.e. hβ4 EC loop and IC ends); (3) β 4 TM1 1 , which contained hβ1 TM1 on a hβ4 'background' (i.e. hβ4 TM2, EC loop and IC ends); and (4) β 4 TM2 1 , which contained hβ1 TM2 on a hβ4 'background' (i.e. hβ4 TM1, EC loop and IC ends). All constructs were verified by automated sequencing at the Molecular Resource Center, University of Tennessee Health Science Center (UTHSC).
Animal studies are reported in compliance with the AR-RIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Oocytes were removed from X. laevis (Xenopus Express, Brooksville, FL, USA). Frogs were housed in a waterfilled plastic cages in a temperature-and humidity-controlled colony room on a 12 h light/dark cycle. Frogs were given ad libitum access to food and water. Animals were acclimatized to standard housing conditions for 1 week before experiments. Frogs were randomly chosen for oocyte isolation; in turn, oocytes were randomly selected for cRNA injection with different constructs. All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at UTHSC, an AAALAC accredited institution. Isolated oocytes were prepared for cRNA injection as described elsewhere (Dopico et al., 1998) . cRNA was dissolved in diethyl polycarbonate-treated water at 50 (cbv1) and 150 (chimeric βs) ng·μL À1 , with 1 μL aliquots being stored at À80°C.
(I/O) patches, as previously described (Dopico, 2003; Liu et al., 2008; Kuntamallappanavar and Dopico, 2016 were calculated with MaxChelator (WEBMAXC, Stanford Univ., CA, USA) and validated experimentally using Ca 2+ -selective and reference electrodes (Corning Incorporated Science, Corning, NY, USA) as described elsewhere (Dopico, 2003) . Patch-recording glass electrodes were prepared as previously detailed (Dopico et al., 1998) , rendering tip resistances of 0.5-5 MΩ when filled with electrode solution. An Ag/AgCl electrode with gluconate was used as a ground electrode. Experiments were carried out at room temperature (20-22°C). Macroscopic currents were evoked from I/O macropatches held at À80 mV by 100 ms long, 10 mV depolarizing steps from À150 to +150-200 mV. Data were acquired using an EPC8 amplifier (HEKA Electronics, Lambrecht/Pfalz, Germany), low-passed at 1 kHz using an eight-pole Bessel filter (Frequency Devices 902LPF, Haverhill, MA, USA) and digitized at 5 kHz using a Digidata 1320A A/D converter and pCLAMP 8.0 (Molecular Devices, Sunnyvale, CA, USA).
After excision from the cell, the cytosolic side of the membrane patch was exposed to bath solution delivered from a pressurized, automated DAD12 system (ALA Scientific Instruments, New York, NY, USA) via a micropipette tip with an internal diameter of 100 μm. Bath solution with urea iso-osmotically substituting for ethanol was used as control perfusion, with the solution osmolarity ranging from 301-322 mM·kg À1 (Wescor Vapro, Logon, UT, USA).
Cerebral artery pressurization and diameter measurement
Eight-to twelve-week-old male KCNMB1 K/O and C57BL/6 control mice (Jackson laboratory, Bar Harbor, ME) were housed and bred in micro-isolator boxes in a temperatureand humidity-controlled colony room on a 12 h light/dark cycle. Mice were given ad libitum access to food and water. Animals were acclimatized to standard housing conditions for 1 week before the experiments. Animals were decapitated using sharp scissors. All these husbandry conditions and procedures were approved by the UTHSC IACUC. Animals were randomly divided into the different experimental groups. Middle cerebral arteries were isolated on ice, under a microscope (Nikon SMZ645; Nikon), from the mouse brain and cut into 1-to 2-mm-long segments. The endothelium was removed from arteries by passing air bubbles into the vessel lumen for 90 s before vessel cannulation. This method is highly effective for removing the endothelial layer; the absence of a functional endothelium was confirmed by the absence of vasodilatation in response to an endotheliumdependent vasodilator (10 μM acetylcholine), while vasodilatation in response to an endothelium-independent vasodilator (10 μM sodium nitroprusside) was preserved (Liu et al., 2004; Bukiya et al., 2007; 2011b; . Each segment was cannulated at each end in a temperature-controlled, custom-made perfusion chamber. Co., Moriguchi, Japan) attached to an inverted microscope (Nikon Eclipse TS100; Nikon, Tokyo, Japan). The artery external wall diameter was measured using the automatic edge-detection function of IonWizard software (IonOptics, Milton, MA, USA), and captured data were digitized at 1 Hz. Steady-state changes in intravascular pressure were achieved by elevating an attached reservoir filled with PSS and monitored using a pressure transducer (Living Systems Instruments, Burlington, VT, USA). Arteries were first incubated at an intravascular pressure of 10 mmHg for 10 min. Then, intravascular pressure was increased to 60 mmHg and held steady throughout the experiment in order to develop and maintain the arterial myogenic tone. Drugs were dissolved to make stock solutions, diluted in PSS to their final concentration and applied to the artery via chamber perfusion. The effect of a drug application was evaluated at the time it reached a maximal, steady level.
Overexpression of BK-β1 or β1/β4 chimeric proteins in middle cerebral arteries from KCNMB1 K/O mouse using reversible permeabilization
Mice freshly isolated, middle cerebral arteries (endothelium removed) were transfected using reversible permeabilization as previously described (Lesh et al., 1995; Zhao et al., 2008; Adebiyi et al., 2011) . Briefly, arteries were transfected with either empty pcDNA3 vector (negative control) or pcDNA3-containing cDNA of interest. The solution compositions used for reversible permeabilization were as follows. 
Isolation of myocytes from mouse middle cerebral artery
Middle cerebral arteries were dissected out from each brain and myocytes were enzymatically and mechanically isolated following procedures identical to those previously described (Bukiya et al., 2009a) . Our method rendered a cell suspension containing relaxed, individual myocytes (≥5 myocytes/field using a 20X objective) that could be identified under an Olympus IX-70 microscope (Olympus America, Center Valley, PA, USA). The cell suspension was stored on ice, and the cells were used for patch-clamp recordings.
Detection of co-expression of cbv1 and β1 or β1/β4 chimeric proteins on the cell membrane surface by biotinylation
Presence of cbv1 and β1 or β1/β4 proteins on the membrane surface of X. laevis oocytes was detected using the Pierce Cell Surface Protein Isolation kit (Thermo Fisher Scientific, Waltham, MA, USA) following the manufacturer's instructions. Immediately prior to the biotinylation-based labelling and separation of membrane surface proteins, the oocyte's follicular layer was removed to allow access of kit reagents to the cell membrane. The purified surface protein fraction was analysed by Western blotting.
Western blotting
Western blotting was performed as described previously Kuntamallappanavar and Dopico, 2016 Biochemical, immunohistochemical, electrophysiological and arterial diameter determination procedures on the different experimental groups were conducted blindly.
Chemicals
Unless otherwise mentioned, all chemicals were purchased from Sigma-Aldrich. On the day of the experiment, ethanol (100% purity; American Bioanalytical, Natick, MA, USA) was freshly added to the bath solution immediately before recordings. Just before the experiment, lithocholic acid (LCA) (Steraloids, Inc., Newport, RI, USA) was initially dissolved in DMSO to obtain a stock solution of 33 mM. Stock solution was sonicated for 30 min. Then, to obtain final LCA concentration (45 μM), the stock solution was further diluted with either batch solution for patch clamp recordings or PSS for artery pressurization experiments.
Data analysis
Electrophysiology data were analysed with pCLAMP 9.2 (Molecular Devices, Sunnyvale, CA, USA). G(conductance)/ G max -V curves obtained from macroscopic ionic current at steady-state level were fitted to a Boltzmann function of the type G(V) = G max /[1 + exp(ÀV + V 0.5 )k]). Boltzmann fitting routines were run using a Levenberg-Marquardt algorithm to perform nonlinear least squares fits. From G/G max -V plots, we obtained the voltage required to achieve half-maximal conductance (V 0.5 ). Further analysis, plotting and fitting were conducted using Origin 8.5 (Originlab, Northampton, MA, USA) and InStat 3.0 (GraphPad Software, San Diego, CA, USA). Data are expressed as mean ± SEM; n = number of patches. Each patch was obtained from a different oocyte. Statistical analysis was conducted using Student's paired t-test to compare the paired data set (for instance, data before and after ethanol treatment) to determine statistical significance of differences between individual means; ANOVA was used to test the difference among more than two groups. Significance was set at P < 0.05. The data and statistical analyses in this study were blindly conducted and complied with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) .
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www. guidetopharmacology.org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Southan et al., 2016) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2015/16 .
Results
BK β1 enables ethanol-induced inhibition of BK activity
Using excised, cell-free patches under continuous perfusion with highly buffered divalent solutions, we evaluated ethanol action on the activity of channels containing cbv1 and either hβ1 or hβ4. Macroscopic currents were obtained over a wide range of Ca 2+ i (0-100 μM) before, during and after 1 min. Perfusion with 50 mM ethanol. Brief exposure to this ethanol concentration regulates BK activity, whether when recombinant BK proteins heterologously expressed or channels in their native cell membranes are studied . In addition, such ethanol concentration corresponds to blood alcohol levels reached during moderate-heavy episodic drinking (Altura and Altura, 1984; Anderson et al., 1993) . Membrane surface (Supporting Information Figure S1A ) and intracellular (Supporting Information Figure S3A ) protein expression and phenotypes after co-expression of hβ1 with cbv1 have been described elsewhere (Bukiya et al., 2008; Kuntamallappanavar et al., 2014) .
Ethanol activated cbv1 + hβ1 at 0.3 μM Ca i . n = 5 (0.3 μM); n = 6 (3 μM); n = 6 (10 μM); n = 5 (30 μM); n = 5 (100 μM); each patch was excised from a different cell. *Different from control (P < 0.05).
evident as a rightward shift in the G/G max -V plot ( Figure 1C ) and a progressive increase in V 0.5 from the V 0.5 - [Ca 2+ ] i plot ( Figure 1D , E). Thus, ethanol-induced activation-toinhibition crossover for cbv1 + hβ1 occurs at~3 μM ( Figure 1D ). Data are identical to those reporting ethanol action on heteromers formed by cbv1 and β1 cloned from rat cerebral artery myocyte (rβ1) (Bukiya et al., 2009a,b; Kuntamallappanavar and Dopico, 2016) . Similarity in both basal channel activity and ethanol effect is consistent with the high identity (≥83%) between hβ1 and rβ1.
Both β1 TM domains are necessary for β1-dependent facilitation of ethanol-induced channel inhibition
After demonstrating that hβ1 enables ethanol-induced BK inhibition at voltage and Ca 2+ i levels found in the contracting cerebral artery myocyte and having been well documented by us and others that hβ4 does not support this ethanol action (Liu et al., 2008; Martin et al., 2008; Bukiya et al., 2009a; Kuntamallappanavar and Dopico, 2016) , we constructed hβ1/hβ4 chimeras by swapping different subunit domains, in such a way that the swapped regions became progressively smaller. Thus, we investigated ethanol action on the different chimeric constructs co-expressed with cbv1 using experimental conditions, data acquisition and analysis identical to those used with cbv1 ± wtβ1 (Figure 1) (Bukiya et al., 2009a; Kuntamallappanavar and Dopico, 2016) .
We first co-expressed cbv1 with βs that had both TMs from either β1 or β4 on a reciprocal β background (β 1 TMs 4 or β 4 TMs 1 ; Figures 2A and 3A) . Surface (Supporting Information Figures S1B and S2A) and intracellular (Supporting Information Figure S3A , B) expression of constructs was confirmed by surface biotinylation. Ethanol activated cbv1 + β 1 TMs 4 at 0.3-3 μM Ca i respectively. n = 5 (0.3 μM); n = 5 (3 μM); n = 6(10 μM); n = 5 (30 μM); n = 5 (100 μM); each patch was excised from a different cell. *Different from control (P < 0.05).
induced activation turned to progressive inhibition. The latter is evident as a progressive increase in V 0.5 from the V 0.5 - [Ca 2+ ] i plot (P < 0.05) ( Figure 2C, D) . Thus, ethanolinduced activation-to-inhibition crossover for cbv1 + β 1 TMs 4 occurs at~20 μM ( Figure 2C ). Therefore, ethanol modulated cbv1 + β 1 TMs 4 in a Ca 2+ i -dependent pattern identical to that of cbv1 + β4. This outcome indicates that regions that constitute the β1 background (IC ends and EC loops) are not critical for ethanol-induced inhibition of β1-containing BK channels when evaluated at Ca 2+ i levels (4-30 μM) that are found near native BK during contraction of cerebral artery myocytes (Pérez et al., 2001) .
Next, we evaluated ethanol action on cbv1 co-expressed with β 4 TMs 1 . Ethanol activated cbv1 + β 4 TMs 1 at low [Ca 2+ ] i , that is, 0.3 μM, which is evident from a decrease in V 0.5 ( Figure 3B-D) . Ethanol-induced reduction of V 0.5 occurred as far as Ca 2+ i < 3 μM, which is evident from the V 0.5 -[Ca Remarkably, ethanol-induced activation-to-inhibition crossover occurred at~2 μM ( Figure 3C ), which matched that of cbv1 + hβ1 ( Figure 1D ). These results indicate that either or both transmembrane domains from β1 are critical for this subunit to enable inhibition of BK channels by ethanol when evaluated at Ca 2+ i levels that are found near native BK channels during contraction of cerebral artery myocytes (Pérez et al., 2001) .
BK β1 TM2 determines β1 subunit-induced facilitation of channel inhibition by ethanol
To identify whether a particular BK β1 TM was necessary to determine ethanol action on β1-containing BK channels, we first co-expressed cbv1 with a chimera that contained TM1 from β1 on β4 background (β 4 TM1 1 ) ( Figure 4A ). Surface (Supporting Information Figure S2B ) and intracellular (Supporting Information Figure S4 ) expression of the resulting heteromer was confirmed by biotinylation. Ethanol activated cbv1 + β 4 TM1 1 at 0.3-3 μM Ca 2+ i , which is evident from a decrease in V 0.5 ( Figure 4B-D) . This decrease occurred as far as Ca 2+ i < 10 μM, which is evident from the V 0.5 -[Ca (Figure 4C, D) . Thus, ethanol-induced activation-to-inhibition crossover for cbv1 + β 4 TM1 1 occurred at~20 μM ( Figure 4C ). This outcome matches that of cbv1 + β4, indicating that β1 TM1 is not i respectively. n = 5 (0.3 μM); n = 5 (3 μM); n = 6(10 μM); n = 7 (30 μM); n = 6 (100 μM); each patch was excised from a different cell. *Different from control (P < 0.05).
critical for ethanol-induced inhibition of β1-containing BK channels when evaluated at Ca 2+ i levels found near native BK channels during myocyte contraction. Collectively, this finding and the results obtained with cbv1 + β 4 TMs 1 raise the hypothesis that β1 TM2 plays a key role in β1-induced modulation of ethanol action on BK channels.
Thus, we next co-expressed cbv1 with a chimera that contained TM2 from β1 on a β4 background (β 4 TM2 1 ; Figure 5A ). Membrane surface (Supporting Information Figure S2B ) and intracellular (Supporting Information Figure S4 ) expression of cbv1 + β 4 TM2 1 was confirmed by biotinylation. Ethanol activated cbv1 + β 4 TM2 1 channels at 0.3 μM Ca 2+ i , which is evident from a decreased V 0.5 ( Figure 5B-D) . Ethanol-induced reduction of V 0.5 occurred as far as Ca 2+ i < 3 μM, which is evident from the V 0.5 -[Ca Figure 5C ). The activation-to-inhibition crossover matched that of cbv1 + β1, which points at β1 TM2 as the critical region that mediates β1-dependent facilitation of ethanol-induced inhibition of BK channels.
β1 TM2 is required for ethanol-induced inhibition of β1-containing BK channels when studied in the cerebral artery smooth muscle native membrane at physiological conditions of Ca 2+ i and voltage
Data described in the previous section demonstrated the key role of β1 TM2 in facilitating ethanol-induced inhibition of recombinant BK channels after their heterologous expression in Xenopus oocytes membranes. This ethanol action ( Figure 5 ) results in ethanol inhibition of β1-containing BK recombinant channels when the drug is probed at low μM Ca 2+ i levels, that is, levels that are found in the contracting cerebral artery myocyte (Pérez et al., 2001 ). Next, we tested whether β1 TM2 played a role in ethanol inhibition of BK channels when studied in the cerebral artery myocyte itself. Thus, we tested ethanol action in myocytes freshly isolated from KCNMB1 K/O mouse cerebral arteries transfected with (a) empty vector i respectively. n = 6 (0.3 μM); n = 5 (3 μM); n = 5 (10 μM); n = 6 (30 μM); n = 6 (100 μM); each patch was excised from a different cell. *Different from control (P < 0.05).
(pcDNA3), (b) cDNA-coding wild-type (wt) β1, (c) cDNAencoding the β 4 TM1 1 chimera or (d) cDNA-encoding the β 4 TM2 1 chimera. Recordings were obtained in I/O patches to match the patch-clamp configuration used in our studies with recombinant channels, with the membrane potential (À40 mV) and Ca 2+ i (30 μM) set to levels reached near the native channel during cerebral artery myocyte contraction (Pérez et al., 2001) . Consistent with our data obtained in the heterologous system, 50 mM ethanol caused a significant inhibition of BK channels from myocytes obtained from KCNMB1 K/O mouse arteries transfected with wt β1 ( Figure 6E ). This result is similar to that obtained on native BK channels in myocytes from C57BL/6 mouse, which are known to include β1 subunits (Bukiya et al., 2009a ). In contrast, ethanol had no effect on BK channels from myocytes obtained from KCNMB1 K/O mouse arteries transfected with empty vector (Figure 6E ), matching data obtained in myocytes of untransfected arteries from KCNMB1 K/O mice (Bukiya et al., 2009a) . In all groups, the functional presence of the β1 TM2 region was tested by application of 45 μM LCA, as previously described (Bukiya et al., 2007) : LCA significantly activated BK channels from myocytes obtained from KCNMB1 K/O mouse arteries transfected with wt β1 (Figure 6F ). In contrast, LCA had no effect on BK channels obtained from KCNMB1 K/O mouse artery myocytes transfected with empty vector ( Figure 6F ). These data match those obtained from untransfected arteries from C57BL/6 and KCNMB1 K/O mouse, respectively (Bukiya et al., 2007) , and confirm that BK β1 is necessary for ethanol-induced BK channel inhibition (Bukiya et al., 2009a) and LCA-induced activation (Bukiya et al., 2007) in native cerebral artery myocytes. More important, ethanol caused a significant inhibition of myocyte BK channels obtained from KCNMB1 K/O mouse arteries previously transfected with cDNA-encoding β 4 TM2 1 (Figure 6B, E) . In contrast, the alcohol failed to produce a significant effect on myocyte BK channels obtained from KCNMB1 K/O mouse arteries transfected with cDNAencoding β 4 TM1 1 (Figure 6A, E) . These results clearly indicate that β1 TM2 is required for ethanol-induced inhibition of cerebral artery myocyte BK channels under levels of Ca 2+ i and voltage found near native BK channels when these channels exert a negative feedback role on depolarization-induced contraction of cerebral artery myocytes (Pérez et al., 2001) . Lastly, application of LCA caused a significant activation of myocyte BK channels obtained from KCNMB1 K/O mouse arteries transfected with cDNA-encoding β 4 TM2 1 ( Figure 6B, F) but not from those transfected with β 4 TM1 1 ( Figure 6A, F) , which is consistent with the finding that β1TM2 is required i respectively. n = 5 (0.3 μM); n = 6 (3 μM); n = 5 (10 μM); 5 (30 μM); n = 6 (100 μM); each patch was excised from a different cell. *Different from control (P < 0.05).
Figure 6
The second transmembrane domain of BK β1 subunit determines ethanol-induced inhibition of cerebral artery smooth muscle BK channels. Representative BK channel recordings at single-channel resolution obtained from inside-out membrane patches from KCNMB1 K/O mice middle cerebral artery myocytes transfected with β 4 TM1 1 (A, C) or with β 4 TM2 1 (C, D). Recordings were obtained before (top trace on each panel), during (middle trace) and after (bottom trace) patch exposure to 50 mM ethanol (V m = À40 mV; Ca for LCA-induced activation of recombinant BK channels heterologously expressed in Xenopus oocytes (Bukiya et al., 2008) .
BK β1 is required for ethanol-induced cerebral artery constriction
After identifying via electrophysiology the specific β1 region that is responsible for facilitating ethanol-induced inhibition of β1-containing BK channels, whether studied following heterologous expression in Xenopus oocytes or in their native cerebral artery environment, we set to determine any possible contribution of such β1 subunit region to BK-mediated ethanol-induced constriction of cerebral arteries. First, we reassessed the contribution of BK β1 as a whole to ethanolinduced cerebral constriction. Briefly, a 2-mm-long, deendothelialized artery segment was pressurized to 60 mmHg to develop myogenic tone. Then, the vessel external diameter was continuously measured in response to bath perfusion containing the following: (1) depolarizing agent (60 mM KCl), (2) 50 mM ethanol, (3) 45 μM LCA, an LCA concentration that only activates β1-containing BK channels (Bukiya et al., 2007 (Bukiya et al., , 2009a and (4) zero nominal Ca 2+ .
In wt mice (C57BL/6 mice), 50 mM ethanol caused a fully reversible vasoconstriction, which was evident by a reduction in diameter of 7.96 ± 0.82% from pre-ethanol levels ( Figure 7A, C) . This vasoconstrictive response is in agreement with previously published results (Bukiya et al., 2009a,b) and was used as positive control. Moreover, this ethanol action is similar to alcohol-induced constriction of rat middle cerebral artery (Liu et al., 2004) , buttressing the fact that the primary mechanisms mediating ethanol action on cerebral arteries are conserved among the two species. After recovery from ethanol action, wt mouse arteries were probed with 45 μM LCA, which caused a 7.23 ± 0.68% increase in artery diameter over pre-LCA values (Figure 7A, D) . This outcome also matches previous data .
In contrast to wt mouse arteries, ethanol consistently failed to constrict middle cerebral arteries from KCNMB1 K/O mouse ( Figure 7B, C) , indicating that BK β1 is a primary determinant of alcohol-induced cerebral artery constriction. In addition, and in contrast to data from wt mouse, LCA failed to dilate cerebral arteries from KCNMB1 K/O mouse ( Figure 7B, D) , which buttresses the fact that LCA activates myocyte BK channels and vasodilates via β1 (Bukiya et al., 2009b) .
Transfection of KCNMB1 K/O mouse cerebral arteries with β1 or β1/β4 chimeric cDNAs leads to expression of respective proteins while keeping cerebral artery function Before determining which β1 domain was required for ethanol-induced cerebral artery constriction, we assessed the expression of β1 alone or β1/β4 chimeras following reversible permeabilization of the artery. Thus, expression vectors containing β1 or β1/ β4 chimeric cDNAs were transfected into de-endothelized middle cerebral arteries of KCNMB1 K/O mouse. After 3-4 days of transfection, both protein expression and functionality of transfected arteries were tested. Successful in vitro reversible permeabilization and eventual protein expression was determined by Western blotting: arteries subjected to in vitro reversible permeabilization expressed significantly higher levels of β1 (Supporting Information Figure S5 and Figure 8A ) or β1/β4 chimeras (Supporting Information Figure S6 and Figure 8A ) than those of KCNMB1 K/O arteries transfected with empty vector. These results demonstrate the effectiveness of our in vitro reversible permeabilization procedure to express BK accessory subunits, as previously shown for other proteins and tissues (Lesh et al., 1995; Zhang et al., 2005; Zhao et al., 2008; Adebiyi et al., 2011) .
After 3-4 days of transfection with either wt β1 or β1/β4 chimeras, we evaluated the artery diameter constriction in response to 60 mM K + and vasodilatation in response to Ca 2+ -free bath solution to determine the vessel's contractile and dilatory responses respectively. Figure 8B shows one representative trace of KCNMB1 K/O middle cerebral artery diameter following transfection with wt β1. Averaged data of myogenic tone and KCl-induced contractile responses of middle cerebral arteries transfected with either β1 or β1/β4 chimeras are shown in Figure 8C , D. Collectively, results indicate that the reversible permeabilization technique used leads to overexpression of β1 or β1/β4 chimeras and renders functional KCNMB1 K/O arteries that constrict and dilate as untransfected arteries from wt mouse (i.e. β1-containing) do (Bukiya et al., 2009a) .
BK β1 TM2 is necessary for ethanol-induced cerebral artery constriction
Once we established that (1) β1 TM2 is largely responsible for facilitating ethanol-induced inhibition of BK channels and (2) transfection of KCNMB1 K/O mouse middle cerebral arteries leads to overexpression of a β protein construct without perturbing arterial responses to vasomodulators, we determined the contribution of BK β1 TM2 to this subunit-induced facilitation of ethanol-induced cerebral constriction. First, we transfected arteries from KCNMB1 K/O mouse with either empty vector (pcDNA3) or wt β1 and measured changes in arterial diameter in response to 50 mM ethanol and 45 μM LCA to test whether β1-transfected arteries were able to recover sensitivity to ethanol and LCA. Indeed, data showed that ethanol-induced constriction of KCNMB1 K/O mouse arteries transfected with β1 reached 7.76 + 1.2% ( Figure 9B , F). This value is similar to that obtained in wt (C57BL/6) mice ( Figures 7C and 9F ). In contrast, ethanol consistently failed to evoke constriction of KCNMB1 K/O mouse arteries transfected with empty vector ( Figure 9A , F). This outcome matches alcohol's lack of action on KCNMB1 K/O mouse arteries ( Figures 7C and 9F ). In turn, LCA-induced increased diameter of KCNMB1 K/O mouse arteries transfected with β1 reached 8.41 + 2.6% ( Figure 9B , E), which matched data in control C57BL/6 mouse arteries ( Figures 7D and 9E ). In contrast to KCNMB1 K/O mouse arteries transfected with β1, LCA failed to dilate cerebral arteries transfected with empty vector ( Figure 9A , B, F). These results validate earlier findings indicating that BK β1 subunit is necessary for ethanolinduced constriction and LCA-induced dilation of cerebral arteries (Bukiya et al., 2007) . After finding that β1 TM2, yet not TM1, is responsible for β1 facilitation of ethanol inhibition of BK channels when studied under conditions of Ca 2+ i and voltage found in the contracting myocyte (Figures 5 and 6) , we addressed the role of β1 TM2 versus TM1 in ethanol-induced constriction of cerebral arteries. Thus, we transfected KCNMB1 K/O mouse arteries with cDNA-encoding the β 4 TM1 1 chimera and then measured changes in arterial diameter in response to application of ethanol and LCA ( Figure 9C, E, F) . In contrast to control arteries and arteries transfected with wtβ1, ethanol consistently failed to constrict KCNMB1 K/O mouse arteries transfected with β 4 TM1 1 (Figure 9C, F) . This result indicates that the EC loop, TM1 region and IC ends of β1 do not mediate ethanol-induced cerebral artery constriction. Application of LCA also failed to dilate KCNMB1 K/O mouse arteries permeabilized with β 4 TM1 1 (Figure 9C, E) , which is consistent with previous findings showing that LCA action on BK channels requires β1 TM2 (Bukiya et al., 2011a) .
Finally, we transfected KCNMB1 K/O mouse cerebral arteries with cDNA-encoding the β 4 TM2 1 chimera and measured changes in arterial diameter in response to 50 mM ethanol and 45 μM LCA. Functional expression of β 4 TM2 1 and its coupling to the BK channel-forming subunit was confirmed by the artery diameter response to LCA. LCA application dilated these arteries by 6.14 + 1.69% (Figure 9D, E) . This response is similar to the response to LCA from control (C57BL/6) and KCNMB1 K/O mouse arteries transfected with β1 ( Figure 9E ). In contrast to the arteries from KCNMB1 K/O mice, ethanol constricted cerebral arteries transfected with β 4 TM2 1 by 5.73 + 0.37% ( Figure 9D, F) . This constriction is statistically similar to those evoked in KCNMB1 K/O mouse cerebral arteries transfected with wtβ1 and to those in cerebral arteries from control mouse. Collectively, these results demonstrate that BK β1 TM2 is critical for ethanol-induced cerebral artery constriction.
Discussion
Our results demonstrate that β1 TM2 is the critical region for this subunit to facilitate ethanol-induced inhibition of BK currents and cerebral artery constriction. On the one hand, several groups have previously documented that transmembrane regions contribute to the alcohol sensitivity of ligandgated channels of the CYS-loop family, including GABA-A, glycine, nACh and prokaryotic GLIC (Mihic et al., 1997; Borghese et al., 2003; Howard et al., 2011; Naito et al., 2014; Borghese et al., 2016) . On the other hand, alcohol-sensing sites have been mapped to intracellular domains of voltagegated K + channel-forming subunits, as reported for G protein-coupled inwardly-rectifying potassium channels (Aryal et al., 2009 ) and BK themselves . Therefore, our data provide first time evidence that a specific domain of an accessory subunit of a member of the voltageactivated TM6 ion channel superfamily is critical for ethanol action on channel function and vascular physiology. We previously showed that ethanol action on BK (cbv1) channels was Ca 2+ i -depedent, with a drug-induced activation-to-inhibition crossover occurring at~20 μM. The presence of β1 cloned from rat cerebral artery myocytes (rβ1) shifted the crossover to~3 μM (Liu et al., 2008 Bukiya et al., 2009a; Kuntamallappanavar and Dopico, 2016) . Thus, at Ca 2+ i levels (4-30 μM) and voltage range (À60 to À20 mV) found near the native BK channel during contraction of rat cerebral artery myocytes (Pérez et al., 2001) , the presence of β1 leads to alcohol-induced BK current inhibition. Our current data on BK complexes containing β1 cloned from human tissue shifted the activation-to-inhibition crossover to~3 μM, which is identical to alcohol action on cbv1 + rβ1. These data suggest that species differences in β1 subunit do not alter ethanol inhibition of β1-containing BK channels. Further, we speculate that conserved residues between rβ1 and hβ1 participate as 'ethanol-sensors' and thus contribute to ethanol-mediated inhibition of β1-containing BK channels and eventual vasoconstriction.
Considering that β1 TM2 participates in slo1-β1 coupling (Wu et al., 2009 (Wu et al., , 2013 Lee et al., 2010; Kuntamallappanavar et al., 2014) , we propose three mechanisms for the crucial role of such region as an ethanol sensor ( Figure 10 ): (1) BK subunits contain an ethanol recognition site(s) additional to the previously identified ('activatory') site in slo1 . The simplest explanation is that such additional ('inhibitory') site(s) is located in β1 TM2 itself. Thus, upon ethanol binding, conformational changes lead to decrease in channel activity ( Figure 10C computational modelling, point mutagenesis and functional assays will be needed to determine the structural underpinnings leading β1 TM2 to function as an alcohol sensor.
Studies using mslo-dslo chimeras have demonstrated that slo1 N-end and S0 are both critical for the functional effects of β1 (Wallner et al., 1996; Morrow et al., 2006; Lee et al., 2010) . Disulfide cross-linking studies have shown that the N-terminal EC end of S0 is in proximity to S3 and S4 during the voltage-sensor resting state(s) and move in concert during voltage-sensor activation (Wu et al., 2009 (Wu et al., , 2013 Liu et al., 2010) . Amino acid substitutions in S0 disrupt the voltagedependent channel activation of BK channels, underscoring S0 interactions with other membrane-spanning domains of the channel voltage-sensing domain (VSD) (Wallner et al., 1996) . Moreover, disulfide cross-linking studies demonstrated that BK β TM1 and TM2 are packed close to each other at the mouth of the cleft between the VSDs of two adjacent slo1 subunits (Wu et al., 2009 (Wu et al., , 2013 Lee et al., 2010) . Within this cleft, TM1 is close to S1 of one VSD and TM2 is close to S0 of the adjacent VSD (Wu et al., 2009 (Wu et al., , 2013 Lee et al., 2010) . This proposed location for TM1 and TM2 and our previous findings Cartoon showing the different action of ethanol on homomeric slo1 versus heteromeric slo1 + β1 channels and three primary hypotheses to explain the key role of β1 TM2 in ethanol's action on these BK heteromers. (A) At physiological voltage and Ca 2+ i levels (≤20 μM), intoxicating concentrations of ethanol (50 mM) increased the steady-state activity (FrPo) of homomeric slo1 channels, provided that Ca 2+ was bound to its high-affinity binding sites located in the slo1 protein (BK α subunit) cytosolic tail domain (CTD) (Liu et al., 2008) . Ethanol-induced increase in activity is mainly determined by an increase in the channel's apparent affinity for Ca 2+ . (B) At physiological voltage and Ca 2+ i levels found near the BK complex (α + β1 subunits) in the contractile myocyte, 50 mM ethanol inhibits channel activity (Bukiya et al., 2009a) . While an increase in the channel's apparent affinity for Ca 2+ (albeit milder than in homomeric slo1) is still observed, inhibition is determined by ethanol-induced disruption of allosteric coupling between key gating processes in the heteromeric channel . Our current results demonstrate that for such inhibition to occur, the β1 subunit TM2 is uniquely required. The functional link between the β1 subunit TM2 and ethanol-disruption of BK gating is depicted in green. (C) We advance three primary hypotheses to explain the role of β1 TM2: BK subunits contain ethanol recognition site(s) additional to the previously identified ('activatory') site in slo1 . The simplest explanation is that this additional site(s) is located in the β1 TM2 domain itself. Thus, upon ethanol binding, conformational changes lead to a decrease in channel activity (left panel). Another main hypothesis is that the slo1 ethanol activatory site itself may function as an 'inhibitory site' while in the presence of β1 (middle panel). A third main hypothesis states that ethanol intercalation in the lipid bilayer and/or the BK protein-lipid interface, with associated disruption of the channel's lipid micro-environment, leads to reduced channel function, with this perturbation being sensed by the β1 TM2 domain (right panel). FrPo, fractional open channel probability (in arbitrary units); PVSD, pore-voltage sensor domain of slo1 proteins; 1, β1 subunit TM1; 2, β1 subunit TM1. A red arrow denotes channel transition upon ethanol binding to BK subunits; a double headed arrow underscores functional coupling between α and β1 subunits.
( Kuntamallappanavar and Dopico, 2016) . Our current results, however, reveal that only TM2 of β1 is critical for ethanolinduced slo1 + β1 current inhibition, which leads to the speculation that ethanol, acting via β1 TM2, could antagonize β1 actions on distinct aspects of slo1 allosteric coupling. Overall, the presence of β1 increases the channel's apparent Ca 2+ i sensitivity and thereby contributes to the characteristic BK current phenotype (Brenner et al., 2000; Cox and Aldrich, 2000) . Structurally, this β1-induced phenotype essentially requires N-terminus (Orio and Latorre, 2005) or both TMs of β1. Considering the fact that (i) ethanol action on BK channels is selectively dependent on Ca 2+ i and (ii) β1 subunits enhance the channel's apparent Ca 2+ i sensitivity (Brenner et al., 2000; Cox and Aldrich, 2000) , a simple scenario would have been that the β1 subunit regions (N-terminus or TMs) that are involved in determining the β1-induced characteristic increase in the channel's Ca 2+ i sensitivity also determine the channel's ethanol sensitivity. Current data, however, demonstrate that TM2 but neither TM1 nor the N-terminus is necessary to facilitate ethanol-induced BK channel inhibition and subsequent cerebral artery constriction. Therefore, our study reveals that key β1 structural determinants underlying functional coupling between slo1 and β1 subunits do not totally overlap with those involved in ethanol action. This information could be useful to design novel therapeutic agents to counteract ethanol action without altering basal BK channel gating and thus physiology.
Ethanol-induced cerebral artery constriction is likely a contributing pathophysiological mechanism to cerebral vasospasm (Arkwright et al., 1982; Hillbom and Kaste, 1990) . Results from our current study will lead to consider TM2-targeting agents, whether endogenous steroids such as LCA (Bukiya et al., 2007; 2009a,b) or synthetic agents such as hydroxyl-alkynoic acids and HENA to target β1 TM2 and thus oppose alcohol-induced cerebral artery constriction. Future studies using pharmacophore design, chemical data base search, organic synthesis, computational modelling and functional essays on engineered BK channels will help in the rationale design of novel agents that would counteract such effect of ethanol without altering organ physiology, which is not dependent on BK β1 subunits.
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https://doi.org/10.1111/bph.14046 Figure S1 Membrane expression of wt β1 and β 1 TMs 4 constructs when co-expressed with cbv1. (A) Western blots showing the surface presence of β1 when co-expressed with cbv1 in Xenopus oocytes. Blot images containing biotinylated samples (membrane fraction) from oocytes previously uninjected (left), injected with cbv1 cRNA alone (middle), and injected with cbv1 + β1 cRNAs (right). (B) Western blots showing the membrane surface presence of the β 1 TMs 4 construct when coexpressed with cbv1. Oocytes injected with cbv1 + β 1 TMs 4 cRNA (left), cbv1 cRNA (middle), and SHAM (uninjected) oocytes (right) are shown. Western blots were obtained after surface biotinylation of Xenopus oocytes expressing the different constructs. The membrane fraction is characterized by the absence of cytosolic marker, i.e., actin (bottom of gel image). Blot image contain non-biotinylated samples (mostly intracellular fraction) from SHAM oocytes (uninjected) (lane 1), injected with cbv1 cRNA (lane 2), injected with cbv1 + β 4 TM1 1 cRNAs (lane 3), and injected with cbv1 + β 4 TM2 1 cRNAs (lane 4). Western blots were obtained for non-biotinylated cell lysate fraction (intracellular fraction) after surface biotinylation of Xenopus oocytes expressing the different constructs. The non-biotinylated fraction (intracellular fraction) is characterized by the presence of actin protein (bottom gel image). Figure S5 Reversible permeabilization leads to overexpression of BK β1 protein in β1 middle cerebral arteries from β1 knock-out mouse. Representative Western blots showing overexpression of BK β1 proteins in β1 knock-out cerebral arteries transfected with empty vector (i.e., pcDNA3; left lane) or pcDNA3 + BK β1 cDNAs (right lane). Figure S6 Reversible permeabilization leads to overexpression of β1/β4 chimeric proteins in middle cerebral arteries from β1 knock-out mouse. Representative Western blots showing overexpression of β1/β4 chimeric proteins in β1 knock-out cerebral arteries transfected with empty vector (pcDNA3; left lane) or pcDNA3 + β 4 TM1 1 (middle lane) or pcDNA3 + β 4 TM2 1 (right lane) chimera cDNA.
